Jun-Sang Bae
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Jun-Sang Bae has a total of 44 co-authors. Here are the top co-authors by number of shared publications:
- Ji-Hun Mo
Department of Otorhinolaryngology, Dankook University College of Medicine, Cheonan, Republic of Korea
14 shared publications - Eun Hee Kim
Department of Otorhinolaryngology, Dankook University College of Medicine, Cheonan, Republic of Korea
9 shared publications - Ji Hye Kim
Department of Otorhinolaryngology, Dankook University College of Medicine, Cheonan, Republic of Korea
7 shared publications - Gwanghui Ryu
Department of Otorhinolaryngology-Head and Neck Surgery, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Republic of Korea
6 shared publications - Shin Hyuk Yoo
Department of Otorhinolaryngology, Dankook University College of Medicine, Cheonan, Republic of Korea
6 shared publications - Lele Lyu
Department of Otorhinolaryngology, Dankook University College of Medicine, Cheonan, Republic of Korea
4 shared publications
Latest Publications
- Open Access
- 31 March 2026
- Published by Korean Rhinologic Society in Journal of Rhinology
- Vol. 33 (1) , 21-28
How to Identify Type 2 Chronic Rhinosinusitis in East Asian Patients
Chronic rhinosinusitis (CRS) is increasingly recognized as a heterogeneous disease with distinct inflammatory endotypes, among which eosinophilic CRS (ECRS)—a category that substantially overlaps with, but is not equivalent to, Type 2 CRS—is associated with severe symptoms, frequent recurrence, and comorbid asthma. Accurate identification of Type 2 CRS has become clinically essential with the emergence of biologic therapies that target Type 2 inflammatory pathways. However, most diagnostic criteria, including those proposed by European Position Paper on Rhinosinusitis and Nasal Polyps 2020 (EPOS 2020), were developed from Western populations, in which ECRS with nasal polyps predominates. This review critically examines the applicability of these criteria in Asian populations, in which non-eosinophilic and mixed inflammatory endotypes remain prevalent. Evidence from Korean and Japanese cohorts indicates that the EPOS 2020 Type 2 criteria have poor specificity in Asian patients with CRS with nasal polyps, classifying nearly all such patients as Type 2 because of differences in baseline biomarker distributions. We discuss histological thresholds for defining ECRS and highlight that Asian studies support higher tissue eosinophil cut-offs, approximately 70 eosinophils per high-power field (HPF) or around 10% of total inflammatory cells, compared with the 10 eosinophils per HPF recommended by Western guidelines. This review also evaluates outpatient- friendly scoring systems, such as Japanese Epidemiological Survey of Refractory Eosinophilic Chronic Rhinosinusitis (JESREC) and newly proposed Korean diagnostic criteria, as well as emerging machine-learning approaches for noninvasive prediction of ECRS. We conclude that clinicians in Asia should adopt regionally validated criteria that integrate histological, serological, and clinical parameters to accurately identify Type 2 CRS, optimize selection of biologic candidates, and improve prognostic counseling in this population.
- 31 March 2026
- Published by Korean Rhinologic Society in Journal of Rhinology
- Vol. 33 (1) , 21-28
Open AccessHow to Identify Type 2 Chronic Rhinosinusitis in East Asian Patients
Chronic rhinosinusitis (CRS) is increasingly recognized as a heterogeneous disease with distinct inflammatory endotypes, among which eosinophilic CRS (ECRS)—a category that substantially overlaps with, but is not equivalent to, Type 2 CRS—is associated with severe symptoms, frequent recurrence, and comorbid asthma. Accurate identification of Type 2 CRS has become clinically essential with the emergence of biologic therapies that target Type 2 inflammatory pathways. However, most diagnostic criteria, including those proposed by European Position Paper on Rhinosinusitis and Nasal Polyps 2020 (EPOS 2020), were developed from Western populations, in which ECRS with nasal polyps predominates. This review critically examines the applicability of these criteria in Asian populations, in which non-eosinophilic and mixed inflammatory endotypes remain prevalent. Evidence from Korean and Japanese cohorts indicates that the EPOS 2020 Type 2 criteria have poor specificity in Asian patients with CRS with nasal polyps, classifying nearly all such patients as Type 2 because of differences in baseline biomarker distributions. We discuss histological thresholds for defining ECRS and highlight that Asian studies support higher tissue eosinophil cut-offs, approximately 70 eosinophils per high-power field (HPF) or around 10% of total inflammatory cells, compared with the 10 eosinophils per HPF recommended by Western guidelines. This review also evaluates outpatient- friendly scoring systems, such as Japanese Epidemiological Survey of Refractory Eosinophilic Chronic Rhinosinusitis (JESREC) and newly proposed Korean diagnostic criteria, as well as emerging machine-learning approaches for noninvasive prediction of ECRS. We conclude that clinicians in Asia should adopt regionally validated criteria that integrate histological, serological, and clinical parameters to accurately identify Type 2 CRS, optimize selection of biologic candidates, and improve prognostic counseling in this population.
- 1 January 2026
- Published by American Association for the Advancement of Science (AAAS) in Biomaterials Research
- Vol. 30
Injectable Trimethyl Chitosan Hydrogel with Capsaicin Mitigates Functional Pain and Angio-Osteogenic Coupling in an Animal Model of Osteoarthritis
Osteoarthritis (OA) remains a leading cause of disability worldwide, with current therapies limited to symptomatic relief. In this study, we developed and evaluated a thermoresponsive hydrogel system based on N , N , N -trimethyl chitosan (TMC) for the sustained intra-articular delivery of capsaicin, an established analgesic. This study focused on assessing the system’s biocompatibility, anti-inflammatory effects, and its impact on functional recovery in an animal model. A thermoresponsive hydrogel (1% TMC, 10% β-glycerophosphate) was formulated for stable gelation at 37 °C. Biocompatibility was assessed via cell count assays on rat articular chondrocytes and macrophages. Therapeutic impact was evaluated through rotarod performance and histological assessment of cartilage integrity in monoiodoacetate-induced OA in rats. Macrophage polarization was analyzed via immunofluorescence. In vitro, the TMC hydrogel successfully enhanced the biocompatibility of capsaicin while indicating a shift away from proinflammatory (M1) macrophage polarization, reflected in a 25% reduction of CD86 + cells while increasing CD206 + cells by 30%. Furthermore, this group exhibited consistent improvement in rotarod latency for up to 4 weeks post-treatment. Histopathological grading scores corroborated these functional improvements, with OA animal models treated with the TMC hydrogel loaded with capsaicin reaching only an average score of 2 compared to untreated control group’s 6. Immunofluorescence analysis revealed marked reduction in angiogenic and interleukin-6 inflammatory markers compared to control groups. The TMC–capsaicin hydrogel system shows promise as a biocompatible localized injectable treatment for OA. This system was associated with improved functional performance and joint protection, along with reduced inflammatory marker expression and preservation of cartilage tissue integrity.
- 1 January 2026
- Published by American Association for the Advancement of Science (AAAS) in Biomaterials Research
- Vol. 30
Injectable Trimethyl Chitosan Hydrogel with Capsaicin Mitigates Functional Pain and Angio-Osteogenic Coupling in an Animal Model of Osteoarthritis
Osteoarthritis (OA) remains a leading cause of disability worldwide, with current therapies limited to symptomatic relief. In this study, we developed and evaluated a thermoresponsive hydrogel system based on N , N , N -trimethyl chitosan (TMC) for the sustained intra-articular delivery of capsaicin, an established analgesic. This study focused on assessing the system’s biocompatibility, anti-inflammatory effects, and its impact on functional recovery in an animal model. A thermoresponsive hydrogel (1% TMC, 10% β-glycerophosphate) was formulated for stable gelation at 37 °C. Biocompatibility was assessed via cell count assays on rat articular chondrocytes and macrophages. Therapeutic impact was evaluated through rotarod performance and histological assessment of cartilage integrity in monoiodoacetate-induced OA in rats. Macrophage polarization was analyzed via immunofluorescence. In vitro, the TMC hydrogel successfully enhanced the biocompatibility of capsaicin while indicating a shift away from proinflammatory (M1) macrophage polarization, reflected in a 25% reduction of CD86 + cells while increasing CD206 + cells by 30%. Furthermore, this group exhibited consistent improvement in rotarod latency for up to 4 weeks post-treatment. Histopathological grading scores corroborated these functional improvements, with OA animal models treated with the TMC hydrogel loaded with capsaicin reaching only an average score of 2 compared to untreated control group’s 6. Immunofluorescence analysis revealed marked reduction in angiogenic and interleukin-6 inflammatory markers compared to control groups. The TMC–capsaicin hydrogel system shows promise as a biocompatible localized injectable treatment for OA. This system was associated with improved functional performance and joint protection, along with reduced inflammatory marker expression and preservation of cartilage tissue integrity.
- Open Access
- 30 November 2025
- Published by Korean Society of Otorhinolaryngology-Head and Neck Surgery in Clinical and Experimental Otorhinolaryngology
- Vol. 18 (4) , 349-360
Functional and Morphological Changes in the Olfactory Epithelium of Mouse Models With Upper Respiratory Inflammation and Olfactory Dysfunction
Objectives. This study evaluated behavioral test results and histological findings in murine models of allergic rhinitis (AR), chronic rhinosinusitis (CRS), and drug-induced anosmia, comparing outcomes among groups.Methods. This study established a total of six animal model groups (n=5 per group): control; ovalbumin (OVA)-induced AR; OVA/polyinosinic-polycytidylic acid (poly[I:C])-induced neutrophil-dominant rhinitis; OVA/Staphylococcus enterotoxin B-induced CRS; and two anosmia models induced by chronic intranasal administration of ZnSO4 and intraperitoneal injection of 3-methylindole (3-MI). Olfactory function was evaluated using an open-field food-finding test and a T-maze test one week after model induction. Behavioral test results were analyzed with video analysis software (EthoVision XT). Immunofluorescent staining was conducted to assess histological changes in olfactory sensory neurons (OSNs) and olfactory basal cells.Results. In the T-maze test, the OVA and OVA/poly(I:C)-induced rhinitis groups showed increased food-finding time compared with the control and CRS groups. The two anosmia mouse models demonstrated statistically significant differences from all other groups. Food-finding time showed significant positive correlations with two novel variables evaluated in this study: total distance moved and average velocity, in both the open-field and T-maze tests. Histologically, the CRS and two anosmia models exhibited a significant decrease in mature and immature OSNs. Additionally, the two rhinitis groups and the CRS group displayed significant changes in the number of immature OSNs. Changes in the basal cell marker cytokeratin-5 were observed specifically in the 3-MI model.Conclusion. This study demonstrated significant differences in olfactory function and histological changes among various mouse models of upper airway inflammation and drug-induced anosmia, as assessed by histological analysis and behavioral tests. These findings can serve as a reference for future studies on olfaction using mouse models.
- 30 November 2025
- Published by Korean Society of Otorhinolaryngology-Head and Neck Surgery in Clinical and Experimental Otorhinolaryngology
- Vol. 18 (4) , 349-360
Open AccessFunctional and Morphological Changes in the Olfactory Epithelium of Mouse Models With Upper Respiratory Inflammation and Olfactory Dysfunction
Objectives. This study evaluated behavioral test results and histological findings in murine models of allergic rhinitis (AR), chronic rhinosinusitis (CRS), and drug-induced anosmia, comparing outcomes among groups.Methods. This study established a total of six animal model groups (n=5 per group): control; ovalbumin (OVA)-induced AR; OVA/polyinosinic-polycytidylic acid (poly[I:C])-induced neutrophil-dominant rhinitis; OVA/Staphylococcus enterotoxin B-induced CRS; and two anosmia models induced by chronic intranasal administration of ZnSO4 and intraperitoneal injection of 3-methylindole (3-MI). Olfactory function was evaluated using an open-field food-finding test and a T-maze test one week after model induction. Behavioral test results were analyzed with video analysis software (EthoVision XT). Immunofluorescent staining was conducted to assess histological changes in olfactory sensory neurons (OSNs) and olfactory basal cells.Results. In the T-maze test, the OVA and OVA/poly(I:C)-induced rhinitis groups showed increased food-finding time compared with the control and CRS groups. The two anosmia mouse models demonstrated statistically significant differences from all other groups. Food-finding time showed significant positive correlations with two novel variables evaluated in this study: total distance moved and average velocity, in both the open-field and T-maze tests. Histologically, the CRS and two anosmia models exhibited a significant decrease in mature and immature OSNs. Additionally, the two rhinitis groups and the CRS group displayed significant changes in the number of immature OSNs. Changes in the basal cell marker cytokeratin-5 were observed specifically in the 3-MI model.Conclusion. This study demonstrated significant differences in olfactory function and histological changes among various mouse models of upper airway inflammation and drug-induced anosmia, as assessed by histological analysis and behavioral tests. These findings can serve as a reference for future studies on olfaction using mouse models.
- Open Access
- 13 September 2025
- Published by SAGE Publications in Journal of Tissue Engineering
- Vol. 16
Intranasal delivery systems for traumatic brain injury: Advancements and perspectives
Traumatic brain injury (TBI) is a major cause of mortality and morbidity, commonly leading to long-term impairments in cognition, sensorimotor function, and personality. While neuroprotective drugs have demonstrated some efficacy in vitro cultures and in vivo animal models, their clinical applications remain debated. Intranasal delivery to the brain parenchyma, bypassing the blood-brain barrier for more direct access to target sites, offers a favorable and safe approach. This review illuminates current advancements in intranasal delivery systems for TBI treatment. We begin with an overview of TBI and its current clinical treatment options. We then outline recent developments in intranasal delivery systems of molecules and cells, emphasizing their efficacy in animal models. Finally, we discuss future clinical perspectives on emerging trends, offering insights into leveraging intranasal delivery for effective TBI therapeutics.
- 13 September 2025
- Published by SAGE Publications in Journal of Tissue Engineering
- Vol. 16
Open AccessIntranasal delivery systems for traumatic brain injury: Advancements and perspectives
Traumatic brain injury (TBI) is a major cause of mortality and morbidity, commonly leading to long-term impairments in cognition, sensorimotor function, and personality. While neuroprotective drugs have demonstrated some efficacy in vitro cultures and in vivo animal models, their clinical applications remain debated. Intranasal delivery to the brain parenchyma, bypassing the blood-brain barrier for more direct access to target sites, offers a favorable and safe approach. This review illuminates current advancements in intranasal delivery systems for TBI treatment. We begin with an overview of TBI and its current clinical treatment options. We then outline recent developments in intranasal delivery systems of molecules and cells, emphasizing their efficacy in animal models. Finally, we discuss future clinical perspectives on emerging trends, offering insights into leveraging intranasal delivery for effective TBI therapeutics.
- Open Access
- 20 June 2025
- Published by Wiley in Journal of Orthopaedic Research
- Vol. 43 (9) , 1632-1646
The Interplay of Angiogenesis and Osteogenesis in Non‐Stabilized Incomplete Tibial Fractures: A Temporal Study in Rats
Prior research on angiogenesis and osteogenesis during bone fracture healing has primarily focused on stabilized models, often within controlled environments. However, the dynamic interplay of these processes in the context of long bone fractures without scaffolds or external factors remains poorly understood. This study investigated the temporal dynamics of angiogenesis and osteogenesis in a non‐stabilized incomplete transverse tibia bone fracture model. Multi‐modal observation approach was carried out using micro‐CT analysis of bone mineral density, histological assessment of fracture healing, and confocal microscopy for visualization and co‐localization of key angiogenic (CD31, endomucin) and osteogenic (collagen 1, osteocalcin, PDGFRB) markers. Our findings revealed a dynamic and interdependent relationship between these processes. H type blood vessels persisted throughout the healing process, and significant correlations were observed between the expression of angiogenic and osteogenic markers. The role of hypoxia, a critical regulator of both processes, was investigated by analyzing HIF1‐α expression. Increased expression of SLIT3, a guidance molecule, was also observed at later stages of healing, suggesting its potential involvement in vascular remodeling. These findings provide crucial insights into the molecular mechanisms underlying bone fracture repair in the absence of additional supporting external elements such as scaffolds or stabilizers. By elucidating the temporal dynamics of these key processes, we identify potential targets for therapeutic interventions aimed at accelerating and optimizing bone regeneration. Consideration of these interactions can lead to the development of effective clinical strategies for enhancing bone healing in non‐stabilized incomplete fractures.
- 20 June 2025
- Published by Wiley in Journal of Orthopaedic Research
- Vol. 43 (9) , 1632-1646
Open AccessThe Interplay of Angiogenesis and Osteogenesis in Non‐Stabilized Incomplete Tibial Fractures: A Temporal Study in Rats
Prior research on angiogenesis and osteogenesis during bone fracture healing has primarily focused on stabilized models, often within controlled environments. However, the dynamic interplay of these processes in the context of long bone fractures without scaffolds or external factors remains poorly understood. This study investigated the temporal dynamics of angiogenesis and osteogenesis in a non‐stabilized incomplete transverse tibia bone fracture model. Multi‐modal observation approach was carried out using micro‐CT analysis of bone mineral density, histological assessment of fracture healing, and confocal microscopy for visualization and co‐localization of key angiogenic (CD31, endomucin) and osteogenic (collagen 1, osteocalcin, PDGFRB) markers. Our findings revealed a dynamic and interdependent relationship between these processes. H type blood vessels persisted throughout the healing process, and significant correlations were observed between the expression of angiogenic and osteogenic markers. The role of hypoxia, a critical regulator of both processes, was investigated by analyzing HIF1‐α expression. Increased expression of SLIT3, a guidance molecule, was also observed at later stages of healing, suggesting its potential involvement in vascular remodeling. These findings provide crucial insights into the molecular mechanisms underlying bone fracture repair in the absence of additional supporting external elements such as scaffolds or stabilizers. By elucidating the temporal dynamics of these key processes, we identify potential targets for therapeutic interventions aimed at accelerating and optimizing bone regeneration. Consideration of these interactions can lead to the development of effective clinical strategies for enhancing bone healing in non‐stabilized incomplete fractures.
- 4 January 2025
- Published by Springer Nature in Inflammation
- Vol. 48 (4) , 2745-2755
Elevated IL-17A-Secreting Regulatory T Cells in Sinonasal Tissues of Chronic Rhinosinusitis with Nasal Polyps
During nasal polyp (NP) development, activated T cells differentiate into T helper (Th) 1, Th2, and Th17 cells. Additionally, regulatory T cells (Tregs) that have an immune suppressive function are involved in the pathophysiology of chronic rhinosinusitis (CRS) with NP (CRSwNP). Tregs can act as effector cells that produce inflammatory cytokines, such as interleukin (IL)-17A. We sought to identify the cellular expression of IL-17A and Treg markers in sinonasal tissue from CRSwNP patients and to investigate whether Tregs are involved in IL-17A secretion. The uncinate process (UP) and NP tissues were harvested from patients with CRSwNP, CRS without NP (CRSsNP), and normal controls. Expression of IL-17A and Foxp3 in each group was observed with immunohistochemistry and immunofluorescence. Expression of IL-17A in Treg was evaluated by flow cytometry of single cells isolated from sinonasal tissues. UP tissue from controls (n = 17), UP from CRSsNP (n = 24), and UP (n = 19) and NP (n = 29) from CRSwNP were obtained. The percentage of Foxp3+ cells was higher in CRS tissues compared with normal controls. IL-17A+ cells were most increased in NP tissues from CRSwNP patients. Expression of IL-17A in some Foxp3+ cells was observed in double immunofluorescence. Foxp3+ cells, IL-17A+ cells, and Foxp3+IL-17A+ cells were increased in the UP and NP tissues from CRSwNP patients. CD45RA−Foxp3+ cells were increased in CRSwNP, and IL-17A+ cells were observed most frequently in CD4+CD45RA−Foxp3+ cells from NP tissues. These findings show that CD4+CD45RA−Foxp3+ Tregs are involved in NP pathogenesis by producing IL-17A.
- 4 January 2025
- Published by Springer Nature in Inflammation
- Vol. 48 (4) , 2745-2755
Elevated IL-17A-Secreting Regulatory T Cells in Sinonasal Tissues of Chronic Rhinosinusitis with Nasal Polyps
During nasal polyp (NP) development, activated T cells differentiate into T helper (Th) 1, Th2, and Th17 cells. Additionally, regulatory T cells (Tregs) that have an immune suppressive function are involved in the pathophysiology of chronic rhinosinusitis (CRS) with NP (CRSwNP). Tregs can act as effector cells that produce inflammatory cytokines, such as interleukin (IL)-17A. We sought to identify the cellular expression of IL-17A and Treg markers in sinonasal tissue from CRSwNP patients and to investigate whether Tregs are involved in IL-17A secretion. The uncinate process (UP) and NP tissues were harvested from patients with CRSwNP, CRS without NP (CRSsNP), and normal controls. Expression of IL-17A and Foxp3 in each group was observed with immunohistochemistry and immunofluorescence. Expression of IL-17A in Treg was evaluated by flow cytometry of single cells isolated from sinonasal tissues. UP tissue from controls (n = 17), UP from CRSsNP (n = 24), and UP (n = 19) and NP (n = 29) from CRSwNP were obtained. The percentage of Foxp3+ cells was higher in CRS tissues compared with normal controls. IL-17A+ cells were most increased in NP tissues from CRSwNP patients. Expression of IL-17A in some Foxp3+ cells was observed in double immunofluorescence. Foxp3+ cells, IL-17A+ cells, and Foxp3+IL-17A+ cells were increased in the UP and NP tissues from CRSwNP patients. CD45RA−Foxp3+ cells were increased in CRSwNP, and IL-17A+ cells were observed most frequently in CD4+CD45RA−Foxp3+ cells from NP tissues. These findings show that CD4+CD45RA−Foxp3+ Tregs are involved in NP pathogenesis by producing IL-17A.
- 19 November 2024
- Published by Wiley in Lasers in Surgery and Medicine
- Vol. 56 (10) , 854-864
Evaluating the Therapeutic Potential of Microneedle Patch Laser With Multiple Wavelengths in Allergic Rhinitis: Insights From an Allergic Rhinitis Mouse Model
Objective: There is insufficient evidence to determine the effectiveness of treating allergic rhinitis with a patch laser affix to the skin as opposed to direct intranasal irradiation of the nasal mucosa. We aimed to evaluate the effect of the microneedle patch laser with multiple wavelengths in an allergic rhinitis (AR) mouse model and its underlying mechanism.Methods: The microneedle patch laser was attached to the skin above the mouse's nasal cavity, transmitting light to the nasal mucosa. For 10 days, the microneedle patch laser administered simultaneous exposure to wavelengths of 670, 780, 850, and 910 nm at either 10 or 20 min each day. Multiple allergic parameters were evaluated following the microneedle patch laser treatment.Results: Microneedle patch laser treatment decreased allergic symptoms and inhibited OVA‐specific IgE levels. Additionally, it significantly reduced eosinophil infiltration, epithelial thickness of the nasal mucosa, and IL‐4 cytokine levels.Conclusion: The light emitted by the microneedle patch laser attached to the skin, penetrated effectively to the nasal mucosa within the nasal cavity, suggesting potential for treating allergic rhinitis in mice and could be extended in clinical applications.
- 19 November 2024
- Published by Wiley in Lasers in Surgery and Medicine
- Vol. 56 (10) , 854-864
Evaluating the Therapeutic Potential of Microneedle Patch Laser With Multiple Wavelengths in Allergic Rhinitis: Insights From an Allergic Rhinitis Mouse Model
Objective: There is insufficient evidence to determine the effectiveness of treating allergic rhinitis with a patch laser affix to the skin as opposed to direct intranasal irradiation of the nasal mucosa. We aimed to evaluate the effect of the microneedle patch laser with multiple wavelengths in an allergic rhinitis (AR) mouse model and its underlying mechanism.Methods: The microneedle patch laser was attached to the skin above the mouse's nasal cavity, transmitting light to the nasal mucosa. For 10 days, the microneedle patch laser administered simultaneous exposure to wavelengths of 670, 780, 850, and 910 nm at either 10 or 20 min each day. Multiple allergic parameters were evaluated following the microneedle patch laser treatment.Results: Microneedle patch laser treatment decreased allergic symptoms and inhibited OVA‐specific IgE levels. Additionally, it significantly reduced eosinophil infiltration, epithelial thickness of the nasal mucosa, and IL‐4 cytokine levels.Conclusion: The light emitted by the microneedle patch laser attached to the skin, penetrated effectively to the nasal mucosa within the nasal cavity, suggesting potential for treating allergic rhinitis in mice and could be extended in clinical applications.
- Open Access
- 31 July 2024
- Published by Korean Rhinologic Society in Journal of Rhinology
- Vol. 31 (2) , 67-77
Epithelial-Mesenchymal Transition in Chronic Rhinosinusitis
Chronic rhinosinusitis (CRS) is characterized by prolonged inflammation of the nasal and paranasal sinus mucosa lasting over 12 weeks. CRS is divided into two main types based on the presence of nasal polyps: CRS without nasal polyps and CRS with nasal polyps. The condition is further classified into endotypes based on type 1, type 2, and type 3 inflammatory signatures, with differences in terms of disease severity, prognosis, and treatment response. Recent studies have emphasized the importance of the epithelial-mesenchymal transition (EMT) in CRS progression. In CRS, the EMT can be triggered by infections, allergens, hypoxia, and environmental pollutants. Specifically, EMT induction proceeds through the following mechanisms: viral and bacterial infections disrupt the epithelial barrier, house dust mites and other allergens activate the TGF-β and EGFR signaling pathways, hypoxia increases HIF-1α and other mesenchymal markers, and diesel exhaust particles and particulate matter cause oxidative stress. Maintaining the integrity of the epithelial barrier is essential for nasal mucosa homeostasis. In CRS, barrier damage activates repair processes that trigger the EMT, resulting in barrier dysfunction and tissue remodeling. Epithelial barrier dysfunction allows antigens and pathogens to penetrate, perpetuating inflammation and promoting the EMT. This disruption is a hallmark of CRS, emphasizing the importance of barrier integrity in the development of the disease. Key signaling pathways regulating the EMT in CRS include TGF-β, Wnt, HMGB1, AGE/ERK, TNF-α, and various miRNAs. These signaling pathways connect to various downstream pathways, such as the Smad2/3, GSK-3β/β-catenin, RAGE, and NF-κB pathways. This review focuses on the complex mechanisms of the EMT in CRS, emphasizing the role of epithelial barrier dysfunction and subsequent EMT processes in driving the disease’s development and progression. A deeper understanding of these EMT-driven mechanisms will help identify the potential therapeutic targets aimed at restoring epithelial integrity and reversing the EMT.
- 31 July 2024
- Published by Korean Rhinologic Society in Journal of Rhinology
- Vol. 31 (2) , 67-77
Open AccessEpithelial-Mesenchymal Transition in Chronic Rhinosinusitis
Chronic rhinosinusitis (CRS) is characterized by prolonged inflammation of the nasal and paranasal sinus mucosa lasting over 12 weeks. CRS is divided into two main types based on the presence of nasal polyps: CRS without nasal polyps and CRS with nasal polyps. The condition is further classified into endotypes based on type 1, type 2, and type 3 inflammatory signatures, with differences in terms of disease severity, prognosis, and treatment response. Recent studies have emphasized the importance of the epithelial-mesenchymal transition (EMT) in CRS progression. In CRS, the EMT can be triggered by infections, allergens, hypoxia, and environmental pollutants. Specifically, EMT induction proceeds through the following mechanisms: viral and bacterial infections disrupt the epithelial barrier, house dust mites and other allergens activate the TGF-β and EGFR signaling pathways, hypoxia increases HIF-1α and other mesenchymal markers, and diesel exhaust particles and particulate matter cause oxidative stress. Maintaining the integrity of the epithelial barrier is essential for nasal mucosa homeostasis. In CRS, barrier damage activates repair processes that trigger the EMT, resulting in barrier dysfunction and tissue remodeling. Epithelial barrier dysfunction allows antigens and pathogens to penetrate, perpetuating inflammation and promoting the EMT. This disruption is a hallmark of CRS, emphasizing the importance of barrier integrity in the development of the disease. Key signaling pathways regulating the EMT in CRS include TGF-β, Wnt, HMGB1, AGE/ERK, TNF-α, and various miRNAs. These signaling pathways connect to various downstream pathways, such as the Smad2/3, GSK-3β/β-catenin, RAGE, and NF-κB pathways. This review focuses on the complex mechanisms of the EMT in CRS, emphasizing the role of epithelial barrier dysfunction and subsequent EMT processes in driving the disease’s development and progression. A deeper understanding of these EMT-driven mechanisms will help identify the potential therapeutic targets aimed at restoring epithelial integrity and reversing the EMT.
- Open Access
- 30 December 2022
- Published by The Korean Society for Laser Medicine and Surgery in Medical Lasers
- Vol. 11 (4) , 208-218
Evaluation of the effects of photobiomodulation treatment on the neuronal development of olfactory stem cells
Reiza Dolendo Ventura, Jun-Sang Bae, Eun Hee Kim, Shin Hyuk Yoo, Gwanghui Ryu, Ji-Hun Mo. Med Lasers 2022;11:208-18. https://doi.org/10.25289/ML.22.048
- 30 December 2022
- Published by The Korean Society for Laser Medicine and Surgery in Medical Lasers
- Vol. 11 (4) , 208-218
Open AccessEvaluation of the effects of photobiomodulation treatment on the neuronal development of olfactory stem cells
Reiza Dolendo Ventura, Jun-Sang Bae, Eun Hee Kim, Shin Hyuk Yoo, Gwanghui Ryu, Ji-Hun Mo. Med Lasers 2022;11:208-18. https://doi.org/10.25289/ML.22.048
- 9 December 2022
- Published by Wiley in Lasers in Surgery and Medicine
- Vol. 55 (2) , 200-207
Electrochemical lipolysis of subcutaneous adipose tissue in a porcine animal model
Objectives: There is a considerable demand for noninvasive low‐cost fat reduction methods with fewer side effects and shorter recovery times. This study aims to develop a fat‐reduction method through electrochemical lipolysis of subcutaneous adipocytes using needle‐based electrodes, body tissue fluids, and electrical current application.Methods: Electrochemical lipolysis was performed by inserting a 4‐pin needle electrode connected to a DC power supply into the pig's abdomen. Applied electrical current (0.5 and 1 mA) and treatment time (5 or 10 minutes) were varied systematically. Ultrasound imaging was performed before and after treatment to determine changes in fat thickness. Tissue samples were collected at 0, 2, and 4 weeks posttreatment for histological evaluation to determine the mechanism of action and the procedure's efficacy.Results: Electrochemical subcutaneous adipose tissue lipolysis in a porcine model was achieved through hydrolysis of physiologic fluid within the vicinity of the inserted electrode where an electric current is applied, leading to localized disruption of fat cell membranes and necrosis. Electric current configuration 1.0 mA showed more pronounced lipolysis effects applied for 10 minutes, significantly decreasing adipocyte content per treatment area. The electrochemical treatment method also stimulates collagen synthesis, which helps reduce fat.Conclusions: Electrochemical lipolysis is a potential new noninvasive localized technique to reduce fat. The treatment method induces fat cell necrosis via in situ reduction‐oxidation reaction by the electrochemical activation of physiologic fluid in the surrounding tissue. Electrochemical lipolysis is a simple, low‐cost, fat‐reducing treatment method without harmful side effects.
- 9 December 2022
- Published by Wiley in Lasers in Surgery and Medicine
- Vol. 55 (2) , 200-207
Electrochemical lipolysis of subcutaneous adipose tissue in a porcine animal model
Objectives: There is a considerable demand for noninvasive low‐cost fat reduction methods with fewer side effects and shorter recovery times. This study aims to develop a fat‐reduction method through electrochemical lipolysis of subcutaneous adipocytes using needle‐based electrodes, body tissue fluids, and electrical current application.Methods: Electrochemical lipolysis was performed by inserting a 4‐pin needle electrode connected to a DC power supply into the pig's abdomen. Applied electrical current (0.5 and 1 mA) and treatment time (5 or 10 minutes) were varied systematically. Ultrasound imaging was performed before and after treatment to determine changes in fat thickness. Tissue samples were collected at 0, 2, and 4 weeks posttreatment for histological evaluation to determine the mechanism of action and the procedure's efficacy.Results: Electrochemical subcutaneous adipose tissue lipolysis in a porcine model was achieved through hydrolysis of physiologic fluid within the vicinity of the inserted electrode where an electric current is applied, leading to localized disruption of fat cell membranes and necrosis. Electric current configuration 1.0 mA showed more pronounced lipolysis effects applied for 10 minutes, significantly decreasing adipocyte content per treatment area. The electrochemical treatment method also stimulates collagen synthesis, which helps reduce fat.Conclusions: Electrochemical lipolysis is a potential new noninvasive localized technique to reduce fat. The treatment method induces fat cell necrosis via in situ reduction‐oxidation reaction by the electrochemical activation of physiologic fluid in the surrounding tissue. Electrochemical lipolysis is a simple, low‐cost, fat‐reducing treatment method without harmful side effects.